Illicit IV Drugs
- 1 November 2002
- journal article
- research article
- Published by Springer Nature in Canadian Journal of Public Health
- Vol. 93 (6) , 431-434
- https://doi.org/10.1007/bf03405031
Abstract
This article explores, from a public health perspective, the harm done by Canadian drug laws, to both individuals and society. It challenges the perceived dichotomy of legalization and criminalization of intravenous drugs. The article then expands the discussion by exploring eight legal options for illicit drugs and examines how these options interact with the marginalization of users, the illicit drug black market, and levels of drug consumption. While the main focus of this article is intravenous drugs, it draws some lessons from cannabis research. Cet article analyse, d’un point de vue de santé publique, les dommages causés aux particuliers et à la société par les lois canadiennes sur les drogues. Il met en question la dichotomie perçue entre la légalisation et la criminalisation des drogues injectées. De plus, l’article analyse huit scénarios juridiques à l’égard des drogues illicites et examine l’effet possible de chaque scénario sur la marginalisation des utilisateurs, le marché noir de la drogue et les niveaux de consommation. Bien que l’article traite surtout des drogues injectées, certaines de ses conclusions proviennent de la recherche sur le cannabis.Keywords
This publication has 8 references indexed in Scilit:
- Evaluating alternative cannabis regimesThe British Journal of Psychiatry, 2001
- The Impact of Cannabis Decriminalisation in Australia and the United StatesJournal of Public Health Policy, 2000
- The Globalization of AddictionAddiction Research, 2000
- DiscussionInternational Journal of Drug Policy, 1999
- Reducing the Harms of Drug Policy: An Economic PerspectiveSubstance Use & Misuse, 1999
- An Economic Analysis of Drug Use and CrimeJournal of Drug Issues, 1998
- The Impact of Marijuana Decriminalization: An UpdateJournal of Public Health Policy, 1989